Literature DB >> 3403713

Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.

P De Feo1, V Gallai, G Mazzotta, G Crispino, E Torlone, G Perriello, M M Ventura, F Santeusanio, P Brunetti, G B Bolli.   

Abstract

To establish the glycemic threshold for onset of neuroglycopenia (impaired cognitive function, measured by the latency of the P300 wave), activation of hormonal counterregulation and hypoglycemic symptoms, 12 normal subjects were studied either under conditions of insulin-induced, glucose-controlled plasma glucose decrements, or during maintenance of euglycemia. A decrement in plasma glucose concentration from 88 +/- 3 to 80 +/- 1 mg/dl for 150 min did not result in changes in the latency of the P300 wave nor in an activation of counterregulatory hormonal response. In contrast, a greater decrement in plasma glucose concentration from 87 +/- 3 to 72 +/- 1 mg/dl for 120 min caused an increase in the latency of the P300 wave (from 301 +/- 12 to 348 +/- 20 ms, P less than 0.01), a subsequent increase in all counterregulatory hormones but no hypoglycemic symptoms. Finally, when plasma glucose concentration was decreased in a stepwise manner from 88 +/- 2 to 50 +/- 1 mg/dl within 75 min, the increase in the latency of the P300 wave was correlated with the corresponding plasma glucose concentration (r = -0.76, P less than 0.001). The glycemic threshold for hypoglycemic symptoms was 49 +/- 2 mg/dl. Thus, in normal man the glycemic threshold for neuroglycopenia (72 +/- 1 mg/dl) is greater than currently thought; the hormonal counterregulation follows the onset of neuroglycopenia; the hypoglycemic symptoms are a late indicator of advanced neuroglycopenia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403713      PMCID: PMC303532          DOI: 10.1172/JCI113616

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.

Authors:  M Da Prada
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

3.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

Authors:  E A McGuire; J H Helderman; J D Tobin; R Andres; M Berman
Journal:  J Appl Physiol       Date:  1976-10       Impact factor: 3.531

4.  Evoked-potential correlates of stimulus uncertainty.

Authors:  S Sutton; M Braren; J Zubin; E R John
Journal:  Science       Date:  1965-11-26       Impact factor: 47.728

5.  Late components of the visual evoked potential to search in short-term memory.

Authors:  N Adam; G I Collins
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1978-02

6.  Psychophysiology of P300.

Authors:  W S Pritchard
Journal:  Psychol Bull       Date:  1981-05       Impact factor: 17.737

7.  Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events.

Authors:  E Halgren; N K Squires; C L Wilson; J W Rohrbaugh; T L Babb; P H Crandall
Journal:  Science       Date:  1980-11-14       Impact factor: 47.728

8.  Long latency event-related components of the auditory evoked potential in dementia.

Authors:  D S Goodin; K C Squires; A Starr
Journal:  Brain       Date:  1978-12       Impact factor: 13.501

9.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

10.  Age-related variations in evoked potentials to auditory stimuli in normal human subjects.

Authors:  D S Goodin; K C Squires; B H Henderson; A Starr
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1978-04
View more
  20 in total

1.  Changes in central and peripheral nervous system function during hypoglycemia in man: an electro-physiological quantification.

Authors:  G Tamburrano; N Locuratolo; G Pozzessere; O Lostia; S Caiola; E Valle; F Bianco; A Giaccari; P A Rizzo
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring.

Authors:  M Trovati; S Burzacca; E Mularoni; P Massucco; F Cavalot; L Mattiello; G Anfossi
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

Review 3.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

4.  Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man.

Authors:  G Tallroth; M Lindgren; G Stenberg; I Rosen; C D Agardh
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

5.  Dynamics of blood electrolytes in repeated hyper- and/or hypoglycaemic events in patients with type 1 diabetes.

Authors:  A Caduff; H U Lutz; L Heinemann; G Di Benedetto; M S Talary; S Theander
Journal:  Diabetologia       Date:  2011-06-15       Impact factor: 10.122

Review 6.  Prevention and management of neonatal hypoglycaemia.

Authors:  J M Hawdon; M P Ward Platt; A Aynsley-Green
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

7.  Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM.

Authors:  A Maran; J Lomas; I A Macdonald; S A Amiel
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

8.  Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans.

Authors:  C Fanelli; A Di Vincenzo; F Modarelli; M Lepore; M Ciofetta; L Epifano; S Pampanelli; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

9.  Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.

Authors:  C Fanelli; S Pampanelli; L Epifano; A M Rambotti; A Di Vincenzo; F Modarelli; M Ciofetta; M Lepore; B Annibale; E Torlone
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

10.  Effects of previous glycaemic control on the onset and magnitude of cognitive dysfunction during hypoglycaemia in type 1 (insulin-dependent) diabetic patients.

Authors:  D Ziegler; A Hübinger; H Mühlen; F A Gries
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.